ALVR

AlloVir Stock Price

34.97
0.40 (1.16%)
Upgrade to Real-Time
Afterhours (Closed)
34.97
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
AlloVir Inc ALVR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.40 1.16% 34.97 13:02:00
Open Price Low Price High Price Close Price Previous Close
34.90 33.91 35.27 34.97 34.57
Bid Price Ask Price Spread News
25.46 39.87 14.41 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
870 40,687 $ 34.51 $ 1,404,089 157,977 20.77 - 45.28
Last Trade Time Type Quantity Stock Price Currency
13:13:45 3 $ 34.97 USD

AlloVir Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.19B 62.67M 27.88M $ 165.00k $ - -0.64 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 71.11M 15.80%

more financials information »

AlloVir News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALVR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week32.9736.475832.9734.11107,5482.006.07%
1 Month26.2536.475824.5831.12140,7748.7233.22%
3 Months28.5436.475820.7727.53292,2146.4322.53%
6 Months22.8245.2820.7729.68324,61412.1553.24%
1 Year22.8245.2820.7729.68324,61412.1553.24%
3 Years22.8245.2820.7729.68324,61412.1553.24%
5 Years22.8245.2820.7729.68324,61412.1553.24%

AlloVir Description

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.


Your Recent History
NASDAQ
ALVR
AlloVir
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.